Allergens for Subcutaneous Immune Therapy

Therapy allergens are used for Allergen immunotherapy (AIT) in order to restore tolerance to the respective allergen.

In the case of the subcutaneous immune therapy (also called subcutaneous hyposensitisation), the allergen extract is injected into the skin in partly increasing doses over a longer period of time (as a rule several years).

Therapy allergens for the subcutaneous immune therapy are available for the following allergen classes:

• Tree Pollen
• Grass-, Cereal and Herbal Pollen
• House Dust Mites
• Insect Venoms

top

Tree Pollen

Approved Allergens for Subcutaneous Immune Therapy against Tree Pollen

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 534 in BAnz AT 29.10.2025 B5.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

top

Grass- / Cereal- / Herbal pollen

Approved Allergens for Subcutaneous Immune Therapy against against Grass-, Cereal- and Herbal Pollen

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 534 in BAnz AT 29.10.2025 B5.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

House Dust Mites

Approved Allergens for Subcutaneous Immune Therapy against House Dust Mites

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 534 in BAnz AT 29.10.2025 B5.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Insect Venoms

Approved Allergens for Subcutaneous Immune Therapy against Insect Venoms

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 534 in BAnz AT 29.10.2025 B5.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.